Date | Open | Close | Daily High | Daily Low |
---|
Date | Analyst | Rating | Price | |||
---|---|---|---|---|---|---|
05/14/25 | Mizuho | Maintained Hold | $32 | |||
05/14/25 | Barclays Capital | Maintained Hold | $28 | |||
04/09/25 | Guggenheim | Maintained Buy | $36 | |||
03/25/25 | Mizuho | Maintained Hold | $37 | |||
03/03/25 | RBC Capital Markets | Maintained Buy | $43 | |||
02/28/25 | Barclays Capital | Downgraded to Hold | $35 | |||
02/28/25 | Bank of America Merrill Lynch | Maintained Buy | $44.5 | |||
07/09/24 | Cantor Fitzgerald | Maintained Hold | $90 | |||
07/02/24 | Cantor Fitzgerald | Maintained Hold | $90 | |||
05/22/24 | RBC Capital Markets | Maintained Buy | $94 | |||
05/15/24 | Barclays Capital | Maintained Buy | $89 | |||
05/03/24 | Mizuho | Maintained Hold | $70 | |||
05/02/24 | Bank of America Merrill Lynch | Maintained Buy | $90 | |||
05/02/24 | Barclays Capital | Maintained Buy | $91 | |||
04/25/24 | Deutsche Bank | Upgraded to Hold | $70 | |||
03/06/24 | Mizuho | Maintained Hold | $84 | |||
03/06/24 | Barclays Capital | Maintained Buy | $100 | |||
03/05/24 | Cantor Fitzgerald | Maintained Hold | $90 | |||
03/04/24 | RBC Capital Markets | Maintained Buy | $94 | |||
02/28/24 | UBS | Maintained Buy | $102 | |||
01/05/24 | Stephens Inc. | Upgraded to Buy | $92 | |||
11/07/23 | RBC Capital Markets | Maintained Buy | $94 | |||
09/14/23 | Cantor Fitzgerald | Maintained Hold | $85 | |||
07/31/23 | RBC Capital Markets | Maintained Buy | $99 | |||
07/31/23 | Credit Suisse | Maintained Buy | $95 | |||
07/12/23 | Stephens Inc. | Maintained Hold | $83 |
2025 | 2026 | 2027 | 2028 | 2029 | |
---|---|---|---|---|---|
Revenue | 3,339 | 3,625 | 3,897 | 4,344 | 4,741 |
Dividend | - | 0.00 | 0.00 | - | - |
Dividend Yield (in %) | 0.00 % | 0.00 % | 0.00 % | - | - |
EPS | 2.66 | 2.97 | 3.20 | 3.77 | 4.26 |
P/E Ratio | 7.97 | 7.16 | 6.64 | 5.63 | 4.98 |
EBIT | - | - | 606 | 637 | 704 |
EBITDA | 696 | 764 | 831 | 908 | 984 |
Net Profit | 246 | 276 | 295 | 324 | 372 |
Net Profit Adjusted | 246 | 276 | 295 | 324 | 372 |
Pre-Tax Profit | 339 | 379 | 406 | 441 | 509 |
Pre-Tax Profit Reported | 291 | 373 | - | - | - |
EPS (Non-GAAP) ex. SOE | 2.66 | 2.97 | 3.20 | 3.77 | 4.26 |
EPS (GAAP) | 2.44 | 2.92 | 3.20 | 3.77 | 4.26 |
Gross Income | - | - | - | - | - |
Cash Flow from Investing | -662 | -529 | -573 | -596 | -608 |
Cash Flow from Operations | 465 | 548 | 613 | 699 | 730 |
Cash Flow from Financing | 189 | 25 | 45 | -50 | -52 |
Cash Flow per Share | - | - | 5.38 | - | - |
Free Cash Flow | -218 | 104 | 152 | 240 | 276 |
Free Cash Flow per Share | -2.86 | 0.17 | 0.96 | 1.12 | 1.33 |
Book Value per Share | - | - | 41.26 | - | - |
Net Debt | 2,175 | 2,206 | 2,179 | 2,185 | 2,114 |
Research & Development Exp. | - | - | - | - | - |
Capital Expenditure | 654 | 481 | 442 | 353 | 359 |
Selling, General & Admin. Exp. | 1,808 | 1,929 | 2,059 | - | - |
Shareholder’s Equity | 3,299 | 3,609 | 3,907 | 4,154 | 4,544 |
Total Assets | 6,491 | 6,908 | 7,416 | 7,848 | 8,358 |
Previous Quarter ending 03/31/25 |
Current Quarter ending 06/30/25 |
Next Quarter ending 09/30/25 |
Current Year ending 12/31/25 |
Next Year ending 12/31/26 |
|
---|---|---|---|---|---|
Earnings Estimates | |||||
No. of Analysts | - | 14 | 14 | 13 | 14 |
Average Estimate | - | 0.698 USD | 0.864 USD | 2.664 USD | 2.966 USD |
Year Ago | - | 0.857 USD | 0.743 USD | 2.790 USD | - |
Publish Date | - | 8/5/2025 | 10/30/2025 | - | - |
Revenue Estimates | |||||
No. of Analysts | - | 12 | 12 | 12 | 12 |
Average Estimate | - | 839 USD | 879 USD | 3,339 USD | 3,625 USD |
Year Ago | - | 796 USD | 816 USD | 3,154 USD | - |
Publish Date | - | 8/5/2025 | 10/30/2025 | - | - |
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Sales | 3,153.96 | 2,928.74 | 2,610.40 | 2,314.39 | 2,089.93 | 3,107.46 | 3,012.44 |
Change of sales in % | 7.69 | 12.20 | 12.79 | 10.74 | -32.74 | 3.15 | 6.21 |
Gross profit on sales | 711.98 | 682.61 | 604.26 | 533.31 | 453.28 | 645.52 | 640.17 |
Gross profit on sales change in % | 4.30 | 12.97 | 13.30 | 17.66 | -29.78 | 0.84 | 0.96 |
Operating income | 522.28 | 506.60 | 446.24 | 396.57 | 332.79 | 404.53 | 412.74 |
Operating income change in % | 3.10 | 13.52 | 12.52 | 19.17 | -17.74 | -1.99 | -5.74 |
Income before tax | 341.88 | -25.36 | 374.14 | 275.76 | 183.80 | 135.99 | -168.95 |
Income before tax change in % | - | - | 35.68 | 50.04 | 35.16 | - | - |
Income after tax | 255.61 | -21.67 | 273.14 | 203.28 | 140.26 | 108.92 | -175.75 |
Income after tax change in % | - | - | 34.37 | 44.93 | 28.77 | - | - |
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Total liabilities | 2,766.08 | 2,471.18 | 2,086.92 | 2,185.20 | 4,544.59 | 4,340.61 | 3,810.39 |
Long-term liabilities per share | 23.84 | 17.37 | 18.89 | 20.00 | 36.77 | 44.20 | 38.81 |
Equity | 3,190.83 | 2,887.66 | 2,900.98 | 2,582.88 | 1,954.77 | 2,538.53 | 2,362.11 |
Equity change in % | 10.49 | -1.09 | 11.73 | 32.54 | -24.18 | 7.37 | -9.31 |
Balance sheet total | 5,956.92 | 5,358.84 | 4,987.90 | 4,768.08 | 6,499.36 | 6,879.14 | 6,172.50 |
Balance sheet total change in % | 11.16 | 7.44 | 4.61 | -26.64 | -5.52 | 11.45 | -3.92 |
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Sales per share | 34.26 | 32.20 | 28.51 | 25.49 | 23.59 | 35.39 | 34.51 |
P/E ratio (year end quote, basic EPS) | 14.28 | - | 27.59 | 27.00 | 22.81 | 26.78 | - |
P/E ratio (year end quote, diluted EPS) | 14.28 | - | 27.59 | 27.00 | 22.81 | 26.78 | - |
Dividend yield in % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity ratio in % | 53.57 | 53.89 | 58.16 | 54.17 | 30.08 | 36.90 | 38.27 |
Debt ratio in % | 46.43 | 46.11 | 41.84 | 45.83 | 69.92 | 63.10 | 61.73 |
Name | Date | shares traded | shares held | Price | type (sell/buy) | option |
---|---|---|---|---|---|---|
Gregg Vicky B | 05/28/2025 | 7,032.00 | 36,297.00 | n/a | Buy | No |
Fucci Michael | 05/28/2025 | 7,032.00 | 21,821.00 | n/a | Buy | No |
KELLY RALPH DAVID | 05/28/2025 | 4,923.00 | 20,027.00 | n/a | Buy | No |
KELLY RALPH DAVID | 05/28/2025 | 7,032.00 | 15,104.00 | n/a | Buy | No |
Bernhard Jason | 05/28/2025 | 4,483.00 | 33,904.00 | n/a | Buy | No |
Bernhard Jason | 05/28/2025 | 7,032.00 | 29,421.00 | n/a | Buy | No |
WAUD REEVE B | 05/28/2025 | 10,637.00 | 59,952.00 | n/a | Buy | No |
WAUD REEVE B | 05/28/2025 | 7,032.00 | 49,315.00 | n/a | Buy | No |
Harris Patrice A | 05/28/2025 | 7,032.00 | 11,583.00 | n/a | Buy | No |
Bissell E. Perot | 05/28/2025 | 7,032.00 | 45,655.00 | n/a | Buy | No |
Miquelon Wade D | 05/28/2025 | 7,032.00 | 55,520.00 | n/a | Buy | No |
GRIECO WILLIAM | 05/28/2025 | 4,395.00 | 89,881.00 | n/a | Buy | No |
GRIECO WILLIAM | 05/28/2025 | 7,032.00 | 85,486.00 | n/a | Buy | No |
HUNTER CHRISTOPHER H. | 05/08/2025 | 1,889.00 | 263,994.00 | 24.22 | Sell | No |
Farley Brian | 05/04/2025 | 38,606.00 | 73,022.00 | n/a | Buy | No |
HUNTER CHRISTOPHER H. | 05/04/2025 | 115,818.00 | 247,102.00 | n/a | Buy | No |
HUNTER CHRISTOPHER H. | 05/04/2025 | 18,781.00 | 265,883.00 | n/a | Buy | No |
Khan Nasser | 05/04/2025 | 30,676.00 | 55,996.00 | n/a | Buy | No |
Dixon Heather Brianne | 05/04/2025 | 43,823.00 | 122,499.00 | n/a | Buy | No |
HUNTER CHRISTOPHER H. | 04/10/2025 | 1,477.00 | 131,284.00 | 27.08 | Sell | No |
HUNTER CHRISTOPHER H. | 02/26/2025 | 16,995.00 | 132,761.00 | 40.26 | Sell | No |
Farley Brian | 02/26/2025 | 2,530.00 | 34,416.00 | n/a | Buy | No |
HUNTER CHRISTOPHER H. | 02/26/2025 | 13,124.00 | 149,756.00 | n/a | Buy | No |
HUNTER CHRISTOPHER H. | 02/26/2025 | 6,672.00 | 136,632.00 | n/a | Buy | No |
Dixon Heather Brianne | 02/26/2025 | 11,659.00 | 78,676.00 | n/a | Buy | No |
Date | Name | Dividend | *yield | Currency |
---|---|---|---|---|
2024 | Acadia Healthcare Co Inc | 0.00 | 0.00 | USD |
2023 | Acadia Healthcare Co Inc | 0.00 | 0.00 | USD |
2022 | Acadia Healthcare Co Inc | 0.00 | 0.00 | USD |
2021 | Acadia Healthcare Co Inc | 0.00 | 0.00 | USD |
2020 | Acadia Healthcare Co Inc | 0.00 | 0.00 | USD |
2019 | Acadia Healthcare Co Inc | 0.00 | 0.00 | USD |
2018 | Acadia Healthcare Co Inc | 0.00 | 0.00 | USD |
2017 | Acadia Healthcare Co Inc | 0.00 | 0.00 | USD |
2016 | Acadia Healthcare Co Inc | 0.00 | 0.00 | USD |
2015 | Acadia Healthcare Co Inc | 0.00 | 0.00 | USD |
2014 | Acadia Healthcare Co Inc | 0.00 | 0.00 | USD |
2013 | Acadia Healthcare Co Inc | 0.00 | 0.00 | USD |
2012 | Acadia Healthcare Co Inc | 0.00 | 0.00 | USD |
2011 | Acadia Healthcare Co Inc | 0.00 | 0.00 | USD |
2010 | Acadia Healthcare Co Inc | 0.00 | 0.00 | USD |
2009 | Acadia Healthcare Co Inc | 0.00 | 0.00 | USD |
Event | Estimate | Info | Date |
---|---|---|---|
Earnings Report | 0.698 USD | Q2 2025 Earnings Release | 08/05/2025 |
Earnings Report | 0.864 USD | Q3 2025 Earnings Release | 10/30/2025 |
Earnings Report | 0.701 USD | Q4 2025 Earnings Release | 02/26/2026 |
Earnings Report | 0.453 USD | Q1 2026 Earnings Release | 04/23/2026 |
Event | Actual EPS | Info | Date |
---|---|---|---|
Annual General Meeting | 2.780 USD | Annual General Meeting | 05/29/2025 |
Earnings Report | 0.090 USD | Q1 2025 Earnings Release | 05/12/2025 |
Earnings Report | 0.350 USD | Q4 2024 Earnings Release | 02/27/2025 |
Earnings Report | 0.740 USD | Q3 2024 Earnings Release | 10/30/2024 |
Earnings Report | 0.850 USD | Q2 2024 Earnings Release | 07/31/2024 |
Annual General Meeting | -0.240 USD | Annual General Meeting | 05/23/2024 |
Earnings Report | 0.830 USD | Q1 2024 Earnings Release | 05/01/2024 |
Earnings Report | 0.630 USD | Q4 2023 Earnings Release | 02/27/2024 |
Earnings Report | -2.390 USD | Q3 2023 Earnings Release | 11/02/2023 |
Earnings Report | 0.790 USD | Q2 2023 Earnings Release | 07/27/2023 |
Annual General Meeting | 2.980 USD | Annual General Meeting | 05/18/2023 |
Earnings Report | 0.720 USD | Q1 2023 Earnings Release | 04/26/2023 |
Earnings Report | 0.670 USD | Q4 2022 Earnings Release | 02/27/2023 |
Earnings Report | 0.780 USD | Q3 2022 Earnings Release | 10/31/2022 |
Earnings Report | 0.880 USD | Q2 2022 Earnings Release | 07/27/2022 |
Annual General Meeting | 2.100 USD | Annual General Meeting | 05/19/2022 |
Earnings Report | 0.670 USD | Q1 2022 Earnings Release | 05/03/2022 |
Earnings Report | 0.770 USD | Q4 2021 Earnings Release | 02/28/2022 |